These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9513377)

  • 1. [Effects of folic acid supplementation on hyperhomocysteinemia in CAPD patients: effects on unsaturated fatty acids].
    Hirose S; Kim S; Matsuda A; Itakura Y; Matsumura O; Tamura H; Nagasawa R; Mitarai T; Isoda K
    Nihon Jinzo Gakkai Shi; 1998 Jan; 40(1):8-16. PubMed ID: 9513377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
    Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine].
    Hirose S; Kono R; Mitarai T; Isoda K; Kim S; Shimoyama H
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):778-86. PubMed ID: 10655726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial.
    Ossareh S; Shayan-Moghaddam H; Salimi A; Asgari M; Farrokhi F
    Iran J Kidney Dis; 2009 Oct; 3(4):227-33. PubMed ID: 19841527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of plasma homocysteine by folic acid in children with chronic renal failure.
    Kang HG; Lee BS; Hahn H; Lee JH; Ha IS; Cheong HI; Choi Y
    Pediatr Nephrol; 2002 Jul; 17(7):511-4. PubMed ID: 12172764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine concentration changes after renal transplantation in children.
    Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
    Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients?
    Korzets A; Ori Y; Chagnac A; Weinstein T; Herman M; Zevin D; Malachi T; Gafter U
    Clin Nephrol; 2000 Jan; 53(1):48-54. PubMed ID: 10661482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between homocysteine and related amino acids in chronic hemodialysis patients.
    McDonald SP; Whiting MJ; Tallis GA; Barbara JA
    Clin Nephrol; 2001 Jun; 55(6):465-70. PubMed ID: 11434358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure.
    Chauveau P; Chadefaux B; Coudé M; Aupetit J; Kamoun P; Jungers P
    Miner Electrolyte Metab; 1996; 22(1-3):106-9. PubMed ID: 8676798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different doses of folic acid on serum homocysteine level in patients on hemodialysis.
    Tamadon MR; Jamshidi L; Soliemani A; Ghorbani R; Malek F; Malek M
    Iran J Kidney Dis; 2011 Mar; 5(2):93-6. PubMed ID: 21368386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperhomocysteinemia in children on dialysis by folic acid.
    Schröder CH; de Boer AW; Giesen AM; Monnens LA; Blom H
    Pediatr Nephrol; 1999 Sep; 13(7):583-5. PubMed ID: 10460506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
    Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
    Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.